Biotest

Biotest ROA

Delisted

The Return on Assets (ROA) of Biotest (BIO.DE) as of Nov 20, 2026 is 1.84 %. In the previous year, Return on Assets (ROA) was 9.00 % — a change of -79.55% (lower).

ROA

1.84 %

YoY

-79.55%

Last updated:

In 2024, Biotest's return on assets (ROA) was 1.84 %, a -79.55% increase from the 9.00 % ROA in the previous year.

The Biotest ROA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROA
Date
ROA
Jan 1, 2017
-0.36 EUR
Jan 1, 2018
17.43 EUR
Jan 1, 2019
-0.42 EUR
Jan 1, 2020
-2.78 EUR
Jan 1, 2021
-5.74 EUR
Jan 1, 2022
-2.64 EUR
Jan 1, 2023
9.00 EUR
Jan 1, 2024
1.84 EUR
The Biotest ROA history
YEARROAYoY
1.84 %-79.55%
9.00 %-441.60%
-2.64 %-54.11%
-5.74 %+106.87%
-2.78 %+554.56%
-0.42 %-102.43%
17.43 %-4,973.66%
-0.36 %-92.71%
-4.91 %-42.71%
-8.57 %-560.89%
1.86 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Biotest Stock analysis

What does Biotest do? Biotest AG is an innovative and successful company that operates in the fields of medicine, pharmacy, and biotechnology. It was founded in 1946 by Dr. Carl Adolf Vorherr in Dreieich near Frankfurt am Main. The company's original focus was on the development, production, and distribution of blood plasma products. In the 1950s, Biotest expanded into the field of transfusion medicine and began to clinically examine and process blood from donors. It became a leading manufacturer of concentrate preparations for the treatment of immune deficiencies and blood coagulation disorders in the 1960s. In the 1970s, the company became a leading manufacturer of monoclonal and polyclonal antibodies and an important research and development facility for biotechnological applications. Biotest today is divided into five research and business areas: Hematology & Immunology, Clinical Immunology, Biotherapeutics, Dermatology, and Research and Development. The company is globally present with locations in Europe, North America, Asia, and South America. It employs over 2,500 people and its products are available in more than 90 countries. It invests in research and development to stay at the forefront of technology and improve global health. Biotest is one of the most popular companies on Eulerpool.

ROA Details

Understanding Biotest's Return on Assets (ROA)

Biotest's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Biotest's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Biotest's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Biotest’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Biotest stock

Return on Assets (ROA) of Biotest is 1.84 % in 2024.

Return on Assets (ROA) of Biotest changed from 9.00 % to 1.84 %, representing a -79.55% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Assets (ROA) Biotest since 2006 – with annual values, charts, and detailed analysis.

Return on Assets, also known as ROA, is a financial metric used to measure a company's profitability. It is used to determine how effectively a company uses its assets to generate profits. It is also referred to as the ratio of net income to total assets. ROA is an important indicator of a company's overall financial performance as it measures the company's ability to generate more profit from the assets it employs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Assets (ROA)'s Biotest with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Assets (ROA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Assets (ROA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Biotest

All Key Metrics — Biotest